Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Adoptive Cell Transfer Therapy Market Growth (Status and Outlook) 2022-2028

  • LP 4913943
  • 122 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Adoptive Cell Transfer Therapy will have significant change from previous year. According to our (LP Information) latest study, the global Adoptive Cell Transfer Therapy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Adoptive Cell Transfer Therapy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Adoptive Cell Transfer Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Adoptive Cell Transfer Therapy market, reaching US$ million by the year 2028. As for the Europe Adoptive Cell Transfer Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Adoptive Cell Transfer Therapy players cover Novartis AG, Kite Pharma, Pfizer, and Juno Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Adoptive Cell Transfer Therapy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

NK

LAK

DC

CIK

CTL

TIL

TCR-T

CAR-T

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Acute Lymphocytic Leukemia

NHL

Melanoma

Bladder Cancer

Lung Cancer

Head and Neck Cancer

Multiple Myeloma

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Novartis AG

Kite Pharma

Pfizer

Juno Therapeutics

Celgene Corporation

CARsgen Therapeutics

Sorrento Therapeutics

Legend Biotech

Atara Biotherapeutics

Aurora Biopharma

Autolus Therapeutics PLC

Bluebird

Carina Biotech

Athenex

Xiangxue Pharmaceutical (Xiangxue Precision)

Hengrui Yuanzheng

Eureka Therapeutics

WuXi Juno

Shenzhen Inno Immunity

Shenzhen Binde Bio

Kerui Bio

Adaptimmune

Altor Bioscience Corporation

Cellectis

Takara Bio

Unum Therapeutics

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Adoptive Cell Transfer Therapy Market Size 2017-2028

2.1.2 Adoptive Cell Transfer Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Adoptive Cell Transfer Therapy Segment by Type

2.2.1 NK

2.2.2 LAK

2.2.3 DC

2.2.4 CIK

2.2.5 CTL

2.2.6 TIL

2.2.7 TCR-T

2.2.8 CAR-T

2.3 Adoptive Cell Transfer Therapy Market Size by Type

2.3.1 Adoptive Cell Transfer Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)

2.4 Adoptive Cell Transfer Therapy Segment by Application

2.4.1 Acute Lymphocytic Leukemia

2.4.2 NHL

2.4.3 Melanoma

2.4.4 Bladder Cancer

2.4.5 Lung Cancer

2.4.6 Head and Neck Cancer

2.4.7 Multiple Myeloma

2.4.8 Other

2.5 Adoptive Cell Transfer Therapy Market Size by Application

2.5.1 Adoptive Cell Transfer Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)

3 Adoptive Cell Transfer Therapy Market Size by Player

3.1 Adoptive Cell Transfer Therapy Market Size Market Share by Players

3.1.1 Global Adoptive Cell Transfer Therapy Revenue by Players (2020-2022)

3.1.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Players (2020-2022)

3.2 Global Adoptive Cell Transfer Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Adoptive Cell Transfer Therapy by Regions

4.1 Adoptive Cell Transfer Therapy Market Size by Regions (2017-2022)

4.2 Americas Adoptive Cell Transfer Therapy Market Size Growth (2017-2022)

4.3 APAC Adoptive Cell Transfer Therapy Market Size Growth (2017-2022)

4.4 Europe Adoptive Cell Transfer Therapy Market Size Growth (2017-2022)

4.5 Middle East & Africa Adoptive Cell Transfer Therapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas Adoptive Cell Transfer Therapy Market Size by Country (2017-2022)

5.2 Americas Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)

5.3 Americas Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Adoptive Cell Transfer Therapy Market Size by Region (2017-2022)

6.2 APAC Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)

6.3 APAC Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Adoptive Cell Transfer Therapy by Country (2017-2022)

7.2 Europe Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)

7.3 Europe Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Adoptive Cell Transfer Therapy by Region (2017-2022)

8.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)

8.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Adoptive Cell Transfer Therapy Market Forecast

10.1 Global Adoptive Cell Transfer Therapy Forecast by Regions (2023-2028)

10.1.1 Global Adoptive Cell Transfer Therapy Forecast by Regions (2023-2028)

10.1.2 Americas Adoptive Cell Transfer Therapy Forecast

10.1.3 APAC Adoptive Cell Transfer Therapy Forecast

10.1.4 Europe Adoptive Cell Transfer Therapy Forecast

10.1.5 Middle East & Africa Adoptive Cell Transfer Therapy Forecast

10.2 Americas Adoptive Cell Transfer Therapy Forecast by Country (2023-2028)

10.2.1 United States Adoptive Cell Transfer Therapy Market Forecast

10.2.2 Canada Adoptive Cell Transfer Therapy Market Forecast

10.2.3 Mexico Adoptive Cell Transfer Therapy Market Forecast

10.2.4 Brazil Adoptive Cell Transfer Therapy Market Forecast

10.3 APAC Adoptive Cell Transfer Therapy Forecast by Region (2023-2028)

10.3.1 China Adoptive Cell Transfer Therapy Market Forecast

10.3.2 Japan Adoptive Cell Transfer Therapy Market Forecast

10.3.3 Korea Adoptive Cell Transfer Therapy Market Forecast

10.3.4 Southeast Asia Adoptive Cell Transfer Therapy Market Forecast

10.3.5 India Adoptive Cell Transfer Therapy Market Forecast

10.3.6 Australia Adoptive Cell Transfer Therapy Market Forecast

10.4 Europe Adoptive Cell Transfer Therapy Forecast by Country (2023-2028)

10.4.1 Germany Adoptive Cell Transfer Therapy Market Forecast

10.4.2 France Adoptive Cell Transfer Therapy Market Forecast

10.4.3 UK Adoptive Cell Transfer Therapy Market Forecast

10.4.4 Italy Adoptive Cell Transfer Therapy Market Forecast

10.4.5 Russia Adoptive Cell Transfer Therapy Market Forecast

10.5 Middle East & Africa Adoptive Cell Transfer Therapy Forecast by Region (2023-2028)

10.5.1 Egypt Adoptive Cell Transfer Therapy Market Forecast

10.5.2 South Africa Adoptive Cell Transfer Therapy Market Forecast

10.5.3 Israel Adoptive Cell Transfer Therapy Market Forecast

10.5.4 Turkey Adoptive Cell Transfer Therapy Market Forecast

10.5.5 GCC Countries Adoptive Cell Transfer Therapy Market Forecast

10.6 Global Adoptive Cell Transfer Therapy Forecast by Type (2023-2028)

10.7 Global Adoptive Cell Transfer Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Novartis AG

11.1.1 Novartis AG Company Information

11.1.2 Novartis AG Adoptive Cell Transfer Therapy Product Offered

11.1.3 Novartis AG Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Novartis AG Main Business Overview

11.1.5 Novartis AG Latest Developments

11.2 Kite Pharma

11.2.1 Kite Pharma Company Information

11.2.2 Kite Pharma Adoptive Cell Transfer Therapy Product Offered

11.2.3 Kite Pharma Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Kite Pharma Main Business Overview

11.2.5 Kite Pharma Latest Developments

11.3 Pfizer

11.3.1 Pfizer Company Information

11.3.2 Pfizer Adoptive Cell Transfer Therapy Product Offered

11.3.3 Pfizer Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Pfizer Main Business Overview

11.3.5 Pfizer Latest Developments

11.4 Juno Therapeutics

11.4.1 Juno Therapeutics Company Information

11.4.2 Juno Therapeutics Adoptive Cell Transfer Therapy Product Offered

11.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Juno Therapeutics Main Business Overview

11.4.5 Juno Therapeutics Latest Developments

11.5 Celgene Corporation

11.5.1 Celgene Corporation Company Information

11.5.2 Celgene Corporation Adoptive Cell Transfer Therapy Product Offered

11.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Celgene Corporation Main Business Overview

11.5.5 Celgene Corporation Latest Developments

11.6 CARsgen Therapeutics

11.6.1 CARsgen Therapeutics Company Information

11.6.2 CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Offered

11.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 CARsgen Therapeutics Main Business Overview

11.6.5 CARsgen Therapeutics Latest Developments

11.7 Sorrento Therapeutics

11.7.1 Sorrento Therapeutics Company Information

11.7.2 Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Offered

11.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Sorrento Therapeutics Main Business Overview

11.7.5 Sorrento Therapeutics Latest Developments

11.8 Legend Biotech

11.8.1 Legend Biotech Company Information

11.8.2 Legend Biotech Adoptive Cell Transfer Therapy Product Offered

11.8.3 Legend Biotech Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Legend Biotech Main Business Overview

11.8.5 Legend Biotech Latest Developments

11.9 Atara Biotherapeutics

11.9.1 Atara Biotherapeutics Company Information

11.9.2 Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Offered

11.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Atara Biotherapeutics Main Business Overview

11.9.5 Atara Biotherapeutics Latest Developments

11.10 Aurora Biopharma

11.10.1 Aurora Biopharma Company Information

11.10.2 Aurora Biopharma Adoptive Cell Transfer Therapy Product Offered

11.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Aurora Biopharma Main Business Overview

11.10.5 Aurora Biopharma Latest Developments

11.11 Autolus Therapeutics PLC

11.11.1 Autolus Therapeutics PLC Company Information

11.11.2 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Offered

11.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Autolus Therapeutics PLC Main Business Overview

11.11.5 Autolus Therapeutics PLC Latest Developments

11.12 Bluebird

11.12.1 Bluebird Company Information

11.12.2 Bluebird Adoptive Cell Transfer Therapy Product Offered

11.12.3 Bluebird Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Bluebird Main Business Overview

11.12.5 Bluebird Latest Developments

11.13 Carina Biotech

11.13.1 Carina Biotech Company Information

11.13.2 Carina Biotech Adoptive Cell Transfer Therapy Product Offered

11.13.3 Carina Biotech Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Carina Biotech Main Business Overview

11.13.5 Carina Biotech Latest Developments

11.14 Athenex

11.14.1 Athenex Company Information

11.14.2 Athenex Adoptive Cell Transfer Therapy Product Offered

11.14.3 Athenex Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Athenex Main Business Overview

11.14.5 Athenex Latest Developments

11.15 Xiangxue Pharmaceutical (Xiangxue Precision)

11.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Information

11.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Offered

11.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Main Business Overview

11.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Latest Developments

11.16 Hengrui Yuanzheng

11.16.1 Hengrui Yuanzheng Company Information

11.16.2 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Offered

11.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Hengrui Yuanzheng Main Business Overview

11.16.5 Hengrui Yuanzheng Latest Developments

11.17 Eureka Therapeutics

11.17.1 Eureka Therapeutics Company Information

11.17.2 Eureka Therapeutics Adoptive Cell Transfer Therapy Product Offered

11.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Eureka Therapeutics Main Business Overview

11.17.5 Eureka Therapeutics Latest Developments

11.18 WuXi Juno

11.18.1 WuXi Juno Company Information

11.18.2 WuXi Juno Adoptive Cell Transfer Therapy Product Offered

11.18.3 WuXi Juno Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 WuXi Juno Main Business Overview

11.18.5 WuXi Juno Latest Developments

11.19 Shenzhen Inno Immunity

11.19.1 Shenzhen Inno Immunity Company Information

11.19.2 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Offered

11.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Shenzhen Inno Immunity Main Business Overview

11.19.5 Shenzhen Inno Immunity Latest Developments

11.20 Shenzhen Binde Bio

11.20.1 Shenzhen Binde Bio Company Information

11.20.2 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Offered

11.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Shenzhen Binde Bio Main Business Overview

11.20.5 Shenzhen Binde Bio Latest Developments

11.21 Kerui Bio

11.21.1 Kerui Bio Company Information

11.21.2 Kerui Bio Adoptive Cell Transfer Therapy Product Offered

11.21.3 Kerui Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.21.4 Kerui Bio Main Business Overview

11.21.5 Kerui Bio Latest Developments

11.22 Adaptimmune

11.22.1 Adaptimmune Company Information

11.22.2 Adaptimmune Adoptive Cell Transfer Therapy Product Offered

11.22.3 Adaptimmune Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.22.4 Adaptimmune Main Business Overview

11.22.5 Adaptimmune Latest Developments

11.23 Altor Bioscience Corporation

11.23.1 Altor Bioscience Corporation Company Information

11.23.2 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Offered

11.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.23.4 Altor Bioscience Corporation Main Business Overview

11.23.5 Altor Bioscience Corporation Latest Developments

11.24 Cellectis

11.24.1 Cellectis Company Information

11.24.2 Cellectis Adoptive Cell Transfer Therapy Product Offered

11.24.3 Cellectis Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.24.4 Cellectis Main Business Overview

11.24.5 Cellectis Latest Developments

11.25 Takara Bio

11.25.1 Takara Bio Company Information

11.25.2 Takara Bio Adoptive Cell Transfer Therapy Product Offered

11.25.3 Takara Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.25.4 Takara Bio Main Business Overview

11.25.5 Takara Bio Latest Developments

11.26 Unum Therapeutics

11.26.1 Unum Therapeutics Company Information

11.26.2 Unum Therapeutics Adoptive Cell Transfer Therapy Product Offered

11.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.26.4 Unum Therapeutics Main Business Overview

11.26.5 Unum Therapeutics Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Adoptive Cell Transfer Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of NK

Table 3. Major Players of LAK

Table 4. Major Players of DC

Table 5. Major Players of CIK

Table 6. Major Players of CTL

Table 7. Major Players of TIL

Table 8. Major Players of TCR-T

Table 9. Major Players of CAR-T

Table 10. Adoptive Cell Transfer Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 12. Global Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)

Table 13. Adoptive Cell Transfer Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 14. Global Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 15. Global Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)

Table 16. Global Adoptive Cell Transfer Therapy Revenue by Players (2020-2022) & ($ Millions)

Table 17. Global Adoptive Cell Transfer Therapy Revenue Market Share by Player (2020-2022)

Table 18. Adoptive Cell Transfer Therapy Key Players Head office and Products Offered

Table 19. Adoptive Cell Transfer Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 20. New Products and Potential Entrants

Table 21. Mergers & Acquisitions, Expansion

Table 22. Global Adoptive Cell Transfer Therapy Market Size by Regions 2017-2022 & ($ Millions)

Table 23. Global Adoptive Cell Transfer Therapy Market Size Market Share by Regions (2017-2022)

Table 24. Americas Adoptive Cell Transfer Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 25. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Country (2017-2022)

Table 26. Americas Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 27. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)

Table 28. Americas Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 29. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)

Table 30. APAC Adoptive Cell Transfer Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 31. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Region (2017-2022)

Table 32. APAC Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 33. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)

Table 34. APAC Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 35. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)

Table 36. Europe Adoptive Cell Transfer Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 37. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Country (2017-2022)

Table 38. Europe Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 39. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)

Table 40. Europe Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 41. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)

Table 42. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Region (2017-2022)

Table 44. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)

Table 46. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 47. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)

Table 48. Key Market Drivers & Growth Opportunities of Adoptive Cell Transfer Therapy

Table 49. Key Market Challenges & Risks of Adoptive Cell Transfer Therapy

Table 50. Key Industry Trends of Adoptive Cell Transfer Therapy

Table 51. Global Adoptive Cell Transfer Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 52. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Regions (2023-2028)

Table 53. Global Adoptive Cell Transfer Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 54. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Type (2023-2028)

Table 55. Global Adoptive Cell Transfer Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 56. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Application (2023-2028)

Table 57. Novartis AG Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 58. Novartis AG Adoptive Cell Transfer Therapy Product Offered

Table 59. Novartis AG Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Novartis AG Main Business

Table 61. Novartis AG Latest Developments

Table 62. Kite Pharma Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 63. Kite Pharma Adoptive Cell Transfer Therapy Product Offered

Table 64. Kite Pharma Main Business

Table 65. Kite Pharma Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Kite Pharma Latest Developments

Table 67. Pfizer Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 68. Pfizer Adoptive Cell Transfer Therapy Product Offered

Table 69. Pfizer Main Business

Table 70. Pfizer Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Pfizer Latest Developments

Table 72. Juno Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 73. Juno Therapeutics Adoptive Cell Transfer Therapy Product Offered

Table 74. Juno Therapeutics Main Business

Table 75. Juno Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Juno Therapeutics Latest Developments

Table 77. Celgene Corporation Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 78. Celgene Corporation Adoptive Cell Transfer Therapy Product Offered

Table 79. Celgene Corporation Main Business

Table 80. Celgene Corporation Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Celgene Corporation Latest Developments

Table 82. CARsgen Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 83. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Offered

Table 84. CARsgen Therapeutics Main Business

Table 85. CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. CARsgen Therapeutics Latest Developments

Table 87. Sorrento Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 88. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Offered

Table 89. Sorrento Therapeutics Main Business

Table 90. Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Sorrento Therapeutics Latest Developments

Table 92. Legend Biotech Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 93. Legend Biotech Adoptive Cell Transfer Therapy Product Offered

Table 94. Legend Biotech Main Business

Table 95. Legend Biotech Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Legend Biotech Latest Developments

Table 97. Atara Biotherapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 98. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Offered

Table 99. Atara Biotherapeutics Main Business

Table 100. Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Atara Biotherapeutics Latest Developments

Table 102. Aurora Biopharma Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 103. Aurora Biopharma Adoptive Cell Transfer Therapy Product Offered

Table 104. Aurora Biopharma Main Business

Table 105. Aurora Biopharma Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Aurora Biopharma Latest Developments

Table 107. Autolus Therapeutics PLC Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 108. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Offered

Table 109. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Autolus Therapeutics PLC Main Business

Table 111. Autolus Therapeutics PLC Latest Developments

Table 112. Bluebird Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 113. Bluebird Adoptive Cell Transfer Therapy Product Offered

Table 114. Bluebird Main Business

Table 115. Bluebird Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. Bluebird Latest Developments

Table 117. Carina Biotech Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 118. Carina Biotech Adoptive Cell Transfer Therapy Product Offered

Table 119. Carina Biotech Main Business

Table 120. Carina Biotech Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. Carina Biotech Latest Developments

Table 122. Athenex Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 123. Athenex Adoptive Cell Transfer Therapy Product Offered

Table 124. Athenex Main Business

Table 125. Athenex Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 126. Athenex Latest Developments

Table 127. Xiangxue Pharmaceutical (Xiangxue Precision) Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 128. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Offered

Table 129. Xiangxue Pharmaceutical (Xiangxue Precision) Main Business

Table 130. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 131. Xiangxue Pharmaceutical (Xiangxue Precision) Latest Developments

Table 132. Hengrui Yuanzheng Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 133. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Offered

Table 134. Hengrui Yuanzheng Main Business

Table 135. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 136. Hengrui Yuanzheng Latest Developments

Table 137. Eureka Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 138. Eureka Therapeutics Adoptive Cell Transfer Therapy Product Offered

Table 139. Eureka Therapeutics Main Business

Table 140. Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 141. Eureka Therapeutics Latest Developments

Table 142. WuXi Juno Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 143. WuXi Juno Adoptive Cell Transfer Therapy Product Offered

Table 144. WuXi Juno Main Business

Table 145. WuXi Juno Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 146. WuXi Juno Latest Developments

Table 147. Shenzhen Inno Immunity Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 148. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Offered

Table 149. Shenzhen Inno Immunity Main Business

Table 150. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 151. Shenzhen Inno Immunity Latest Developments

Table 152. Shenzhen Binde Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 153. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Offered

Table 154. Shenzhen Binde Bio Main Business

Table 155. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 156. Shenzhen Binde Bio Latest Developments

Table 157. Kerui Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 158. Kerui Bio Adoptive Cell Transfer Therapy Product Offered

Table 159. Kerui Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 160. Kerui Bio Main Business

Table 161. Kerui Bio Latest Developments

Table 162. Adaptimmune Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 163. Adaptimmune Adoptive Cell Transfer Therapy Product Offered

Table 164. Adaptimmune Main Business

Table 165. Adaptimmune Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 166. Adaptimmune Latest Developments

Table 167. Altor Bioscience Corporation Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 168. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Offered

Table 169. Altor Bioscience Corporation Main Business

Table 170. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 171. Altor Bioscience Corporation Latest Developments

Table 172. Cellectis Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 173. Cellectis Adoptive Cell Transfer Therapy Product Offered

Table 174. Cellectis Main Business

Table 175. Cellectis Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 176. Cellectis Latest Developments

Table 177. Takara Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 178. Takara Bio Adoptive Cell Transfer Therapy Product Offered

Table 179. Takara Bio Main Business

Table 180. Takara Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 181. Takara Bio Latest Developments

Table 182. Unum Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors

Table 183. Unum Therapeutics Adoptive Cell Transfer Therapy Product Offered

Table 184. Unum Therapeutics Main Business

Table 185. Unum Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 186. Unum Therapeutics Latest Developments

List of Figures

Figure 1. Adoptive Cell Transfer Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Adoptive Cell Transfer Therapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Adoptive Cell Transfer Therapy Market Size Market Share by Type in 2021

Figure 7. Adoptive Cell Transfer Therapy in Acute Lymphocytic Leukemia

Figure 8. Global Adoptive Cell Transfer Therapy Market: Acute Lymphocytic Leukemia (2017-2022) & ($ Millions)

Figure 9. Adoptive Cell Transfer Therapy in NHL

Figure 10. Global Adoptive Cell Transfer Therapy Market: NHL (2017-2022) & ($ Millions)

Figure 11. Adoptive Cell Transfer Therapy in Melanoma

Figure 12. Global Adoptive Cell Transfer Therapy Market: Melanoma (2017-2022) & ($ Millions)

Figure 13. Adoptive Cell Transfer Therapy in Bladder Cancer

Figure 14. Global Adoptive Cell Transfer Therapy Market: Bladder Cancer (2017-2022) & ($ Millions)

Figure 15. Adoptive Cell Transfer Therapy in Lung Cancer

Figure 16. Global Adoptive Cell Transfer Therapy Market: Lung Cancer (2017-2022) & ($ Millions)

Figure 17. Adoptive Cell Transfer Therapy in Head and Neck Cancer

Figure 18. Global Adoptive Cell Transfer Therapy Market: Head and Neck Cancer (2017-2022) & ($ Millions)

Figure 19. Adoptive Cell Transfer Therapy in Multiple Myeloma

Figure 20. Global Adoptive Cell Transfer Therapy Market: Multiple Myeloma (2017-2022) & ($ Millions)

Figure 21. Adoptive Cell Transfer Therapy in Other

Figure 22. Global Adoptive Cell Transfer Therapy Market: Other (2017-2022) & ($ Millions)

Figure 23. Global Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021

Figure 24. Global Adoptive Cell Transfer Therapy Revenue Market Share by Player in 2021

Figure 25. Global Adoptive Cell Transfer Therapy Market Size Market Share by Regions (2017-2022)

Figure 26. Americas Adoptive Cell Transfer Therapy Market Size 2017-2022 ($ Millions)

Figure 27. APAC Adoptive Cell Transfer Therapy Market Size 2017-2022 ($ Millions)

Figure 28. Europe Adoptive Cell Transfer Therapy Market Size 2017-2022 ($ Millions)

Figure 29. Middle East & Africa Adoptive Cell Transfer Therapy Market Size 2017-2022 ($ Millions)

Figure 30. Americas Adoptive Cell Transfer Therapy Value Market Share by Country in 2021

Figure 31. Americas Adoptive Cell Transfer Therapy Consumption Market Share by Type in 2021

Figure 32. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021

Figure 33. United States Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 34. Canada Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 35. Mexico Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 36. Brazil Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 37. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Region in 2021

Figure 38. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021

Figure 39. China Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 40. Japan Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 41. Korea Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 42. Southeast Asia Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 43. India Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 44. Australia Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 45. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Country in 2021

Figure 46. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Type in 2021

Figure 47. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021

Figure 48. Germany Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 49. France Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 50. UK Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 51. Italy Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 52. Russia Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 53. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Region in 2021

Figure 54. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Type in 2021

Figure 55. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021

Figure 56. Egypt Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 57. South Africa Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 58. Israel Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 59. Turkey Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 61. Americas Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 62. APAC Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 63. Europe Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 64. Middle East & Africa Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 65. United States Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 66. Canada Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 67. Mexico Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 68. Brazil Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 69. China Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 70. Japan Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 71. Korea Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 72. Southeast Asia Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 73. India Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 74. Australia Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 75. Germany Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 76. France Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 77. UK Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 78. Italy Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 79. Russia Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 80. Spain Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 81. Egypt Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 82. South Africa Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 83. Israel Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 84. Turkey Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

Figure 85. GCC Countries Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450